Cardinal Health reported a bump in revenue in its third quarter, driven by gains in the company's pharmaceutical segment. The Dublin, Ohio-based drug and medical products distributor reported $386 million in earnings during the last quarter, up 6% from last year.
New federal rules will extend Medicaid coverage to nearly 100,000 former prison inmates in halfway houses.
Dr. Andrew Bindman has been named director of the Agency for Healthcare Research and Quality, effective May 2. Sharon Arnold has served as acting director since March, when Richard Kronick stepped down. Kronick had led AHRQ, a division of HHS, since August 2013.
Abbott Laboratories will spend $19.3 billion to buy St. Jude Medical in a cash-stock deal that aims to strengthen the medical-device maker's share of the market for cardiovascular care.
AbbVie on Thursday reported a boost in first-quarter profit on higher sales of the drug Humira and said it will buy cancer drug developer StemCentrx for more than $5.8 billion.
Aetna's total medical membership fell by almost a half million people since the start of the year, but the Hartford, Conn.-based health insurer was still able to build revenue.
Officials for St. John Providence Health System in eastern Michigan say they will appeal a letter terminating Medicare participation for one of its hospitals, effective May 7. The April 14 notification by CMS was over a patient who committed suicide at St. John River District Hospital in St. Clair.
Drugmaker Sanofi says it has made a $9.3 billion bid for San Francisco pharmaceutical firm Medivation, part of the firm's effort to expand its portfolio of cancer treatments.
Birth rates are falling dramatically for black and Hispanic teenagers, but they continue to be much higher than the birth rate for white teens.
Just weeks after the collapse of Pfizer's controversial deal to buy fellow drugmaker Allergan and move its headquarters to Ireland, company executives faced sharp criticism from shareholders at their annual meeting.
The CMS has started to answer the many questions surrounding how physicians will get paid under the Medicare Access and CHIP Reauthorization Act. But some stakeholders were immediately dissatisfied with what they saw, and the 963-page rule may have raised as many questions as it answered.
One of the most comprehensive, independent studies of commercial healthcare prices shows that employers and insurers that provide private health coverage pay a lot more for services depending on the state where people live.